Keywords: ASPE; allele-specific primer extension; CI; confidence interval; DST; drug susceptibility testing; FQs; fluoroquinolones; INH; isoniazid; L-J; Lowenstein-Jensen; LVX; levofloxacin; MDR-TB; multidrug-resistant tuberculosis; MXF; moxifloxacin; OFX; oflo
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Moxibustion; Tuberculosis; HIV; MDR-TB; Immuno-modulation; Immunotherapy; Randomised control trial;
Keywords: Tuberculosis (TB); Multi-drug resistant tuberculosis (MDR-TB); Extensively drug-resistant tuberculosis (XDR-TB); Central nervous system (CNS) TB; Tuberculoma; Bedaquiline; AFB; acid-fast bacilli; BAL; bronchoalveolar lavage; CNS; central nervous system; C
Keywords: Palliative care; hospice; TB; MDR-TB; Worldwide Hospice Palliative Care Alliance; WHO Stop TB;
Keywords: ALG; alginate; Cm; capreomycin; CHI; chitosan; DPIs; dry powder inhalers; E; ethambutol; EC; ethyl cellulose; ECM; extracellular matrix; Eto; ethionamide; FPF; fine particle fraction; HA; hyaluronic acid; HIP/PCA; hydrophobic ion-pairing/precipitation wit
Keywords: Drug resistance; MDR-TB; Second-line drugs; Pre XDR; XDR;
Keywords: Drug-resistant tuberculosis; MDR-TB; Standardized treatment; Treatment outcomes; Tuberculosis;
Keywords: Multidrug-resistant tuberculosis; MDR-TB; Fluoroquinolone; Drug susceptibility testing; Cross-resistance;
Keywords: Transmission; Pharmacogenomics; Incipient tuberculosis; HIV; Diabetes; Biomarkers; DAIDS; Division of AIDS; NIAID; National Institute of Allergy and Infectious Diseases; NIH; National Institutes of Health; TB; tuberculosis; RePORT; Regional Prospective Ob
Keywords: TB; tuberculosis; HIV; human immunodeficiency virus; DPI; dry powder inhaler; AIDS; acquired immunodeficiency syndrome; WHO; world health organization; Mtb; Mycobacterium tuberculosis; AM; alveolar macrophage; PTB; pulmonary TB; EPTB; extra pulmonary TB;
Keywords: Tuberculosis; MDR-TB; XDR-TB; HIV;
Keywords: Tuberculosis; Elimination; MDR-TB; LTBI; Strategy;
Keywords: AFB; Acid Fast Bacilli; ATT; Anti-Tubercular Therapy; BCG; Bacillus Calmette Guerin; CI; Confidence Interval; DST; Drug Susceptibility Testing; HIV; Human Immunodeficiency Virus; IPT; Isoniazid Preventive Therapy; INH; Isoniazid; MDR-TB; Multi Drug Resist
Keywords: Drug adherence; Medication adherence; Smear microscope; Pulmonary tuberculosis; Culture; MDR-TB; Mwanza; Tanzania;
Keywords: MDR-TB; Tuberculosis; Household contacts; Contact tracing; Children; GeneXpert; Index patients;
Keywords: TB; tuberculosis; MTB; Mycobacterium tuberculosis; MDR-TB; multi-drug resistant tuberculosis; XDR-TB; extensively drug resistant tuberculosis; TDR-TB; totally drug resistant tuberculosis; INH; isoniazid; WHO; World Health Organization; RIF; rifampicin; PZ
Keywords: Tuberculosis; Household contacts; MDR-TB; Peshawar; Pakistan
Keywords: MDR-TB; XDR-TB; Imipenem; Linezolid; Effectiveness; Safety; Tolerability;
Keywords: Molecular characterization; Aminoglycosides; MDR-TB; XDR-TB;
Keywords: Anti-tuberculosis drugs; Children; XDR-TB; MDR-TB; Pediatric tuberculosis
Keywords: HIV; human immunodeficiency virus; LTBI; latent tuberculosis infection; MDR-TB; multidrug-drug resistant tuberculosis; Mtb; Mycobacterium tuberculosis; TMPK; thymidine monophosphate kinase; dTMP; thymidine 5â²-monophosphate; dTDP; thymidine 5â²-diphosph
Keywords: Tuberculosis; Pregnancy; Pregnant; HIV; TB; MDR-TB
Keywords: MDR-TB; XDR-TB; Prevention; Treatment; Therapeutic drug monitoring; Drug dosage
Keywords: Mycobacterium tuberculosis; MDR-TB; XDR-TB; Second-line drugs; Elimination; Stop TB strategy;
Keywords: Tryptanthrin; Indolo[2,1-b]quinazoline-6,12-dione; MDR-TB; Enoyl-acyl carrier protein reductase (InhA); In silico molecular docking study
Keywords: Tuberculosis; MDR-TB; host directed therapy; M.tuberculosis; inflammation; Mesenchymal stromal cells; T-cells; cancer; HDT
Keywords: MDR-TB; Diabetes; Latin America
Keywords: Tuberculosis; Prisons; MDR-TB; End TB Strategy; Xpert MTB/RIF; Research
Keywords: HGI; Hunter and Gaston index; MDR-TB; multidrug-resistantMycobacterium tuberculosis; MIRU-VNTR; mycobacterial interspersed repetitive units-variable number of tandem repeats; PCR; polymerase chain reaction;
Keywords: Tuberculosis; MDR-TB; Limit; Transmission; Cluster; Resistance;
Keywords: Mycobacterium tuberculosis; MDR-TB; XDR-TB; Lisboa family
Keywords: Rifampin; Genotypic drug susceptibility testing; MDR-TB; Molecular epidemiology;
Keywords: Cost analysis; Monte Carlo simulation; Tuberculosis; MDR-TB; XDR-TB; Strain resistance;
Keywords: Linezolid; Tuberculosis; MDR-TB; XDR-TB; children;
Keywords: Antitubercular activity; Isoniazid derivatives; Mycobacterium tuberculosis; Resistance; QSARs; Synthesis; AE; average error; AAE; absolute average error; ASNNs; associative neural networks; BCG; Bacillus Calmette-Guérin; CCC; concordance correlation co
Keywords: Tuberculosis; MDR-TB; Resistance; Phenotypic method;
Keywords: Mycobacterium tuberculosis; Spoligotyping; MIRU-VNTR; MDR-TB;
Keywords: AmB; amphotericin B deoxycholate; CDs; cyclodextrins; DDS; drug delivery systems; DPI; dry powder inhalers; DSPC; distearoylphosphatidylcholine; EDTA; ethylenediaminetetraacetic acid; GRAS; generally recognized as safe; MAC; Mycobacterium avium-Mycobact
Keywords: Tuberculosis; Antituberculosis drug resistance; Anti-TB drugs; Diabetes mellitus; MDR-TB
Keywords: MDR-TB; 24-Loci MIRU-VNTR; Spoligotyping; Haarlem 3
Keywords: Fluoroquinolones; MDR-TB; Resistance; Private
Keywords: MDR-TB; Treatment outcome; Risk factors; Physical accessibility; Shanghai
Keywords: Sahariya tribe; Mycobacterium tuberculosis; MDR-TB
Reverse line probe assay for cheap detection of Single Nucleotide Polymorphisms in Mycobacterium tuberculosis
Keywords: SNPs detection; MDR-TB; Molecular detection of RIF resistance; Line probe assay; Global health;
Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond
Keywords: MDR-TB; XDR-TB; Clinical management; Drug resistance; Prevention; Consilium;
Analysis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis isolates in Morocco using GenoType® MTBDRplus assay
Keywords: Mycobacterium tuberculosis; MDR-TB; GenoType MTBDRplus; MIC; Morocco;
Rs4073 single nucleotide polymorphism of interleukin-8 (CXCL8/IL-8) and susceptibility to pulmonary tuberculosis in Gilan, Northern Iran
Keywords: CXCL8/IL-8; Interleukin-8; TB; Tuberculosis; ARMS-PCR; Amplification Refractory Mutation System-polymerase chain reaction; SNP; Single Nucleotide Polymorphism; MDR-TB; Multidrug-resistant TB; IFN-γ; Gamma interferon; ESAT-6; Early secreted antigenic targ
Dissecting whole-genome sequencing-based online tools for predicting resistance in Mycobacterium tuberculosis: can we use them for clinical decision guidance?
Keywords: Multidrug-resistant tuberculosis; Whole-genome sequencing; TB profiler; TGS-TB; PhyResSE; Mykrobe predictor; AMK; Amikacin; CAP; Capreomycin; CICLO; Cicloserine; DST; Drug Susceptibility Testing; EMB; Etambutol; ETH; Ethionamide; FLQ; Fluoroquinolones; IG
Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study
Keywords: Tuberculosis; HIV; MDR-TB; Eastern Europe;
Wild-type catalase peroxidase vs G279D mutant type: Molecular basis of Isoniazid drug resistance in Mycobacterium tuberculosis
Keywords: INH; Isoniazid; KatG; catalase peroxidise; TB; tuberculosis; MDR-TB; multi drug resistant TB; NAD; nicotinamide adenine dinucleotide; ACP; enoyl-acyl carrier protein; H2O2; hydrogen peroxide; SPC/E; extended simple point charge water model; PCA; principal